ALS (Lou Gehrig's Disease) clinical trials in Massachusetts
31 active ALS (Lou Gehrig's Disease) trials with a site in Massachusetts. Describe your situation to see which ones look like a fit.
- Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS
- Tofersen in Non-SOD1 ALS
- Study of COYA 302 for the Treatment of ALS
- RAPA-501 Therapy for ALS
- AMX0114 in Adult Participants With Amyotrophic Lateral Sclerosis
- Controlling Amyotrophic Lateral Sclerosis Motor Neuron Excitability Study
- Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients
- Study is to Assess the Safety and Tolerability of VTx-002 in Participants With ALS
- RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral Sclerosis
- A Study to Learn More About the Long-Term Safety of Tofersen (Qalsody) in Participants With Superoxide Dismutase 1 (SOD-1) Amyotrophic Lateral Sclerosis (ALS)
- ALS Research Collaborative
- PREVENT ALL ALS Study
- ASSESS ALL ALS Study
- EIM Via the Myolex mScan as an ALS Biomarker
- Target ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At Home Measures
- Intermuscular Coherence as a Biomarker for ALS
- ALS/MND Natural History Study Data Repository
- ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)
- BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia
- Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Tablet-01)
- Connect-One: Early Feasibility Study of Connexus® Brain-Computer Interface (BCI)
- Efficacy and Safety of MSC-NTF (NurOwn) in Participants With Early Symptomatic ALS and Moderate Disease Presentation in ALS (ENDURANCE STUDY)
- Resiliency Intervention for Patients With ALS and Their Care-Partners
- Safety Study of XT-150 in Participants With ALS
- A Phase Ⅰ/Ⅱa Study of SNUG01 in Adult Subjects With ALS
- Do Video Recordings of Multidisciplinary Clinics Improve Quality of Life for People With ALS and Their Caregivers?
- HEALEY ALS Platform Trial - Regimen I NUZ-001
- HEALEY ALS Platform Trial - Master Protocol
- Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.